Gladding
Christopher J. Gladding, Danville, CA US
Patent application number | Description | Published |
---|---|---|
20100054286 | Semiconductor Diode Pumped Laser Using Heating-Only Power Stabilization - A laser system such as a DPSS green laser uses a laser diode pump source that is specially selected so that the wavelength of diode source is centered around the optimal source wavelength, typically 808 nm, which produces the optimal green laser output from the system. Unlike prior systems in which the source wavelength is at 808 nm at typical ambient temperature of about 25° C., in the system disclosed, the source wavelength is at 808 nm at a temperature significantly higher than ambient, which may be as high as about 40° C. In this system optimum performance can be established and maintained in a broad temperature range such as 0˜50° C. using only a heating element adjacent to the diode laser pump source. No cooling is required. Cost, size, and power requirements of the system are therefore minimized. | 03-04-2010 |
Derek Gladding, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110208946 | Dual Mode Floating Point Multiply Accumulate Unit - Disclosed are various embodiments of a stream processing unit for single instruction multiple data (SIMD) processing, wherein the stream processing unit executes a stage of a Multiply-Accumulate calculation. In one embodiment, the stream processing unit comprises a plurality of scalar arithmetic logic units (ALUs) configured to receive data having a plurality of data types. The number and type of scalar ALUs corresponds to an SIMD factor. In one embodiment, the scalar ALUs are executed sequentially with a delay being introduced in between execution of each of the scalar ALUs, wherein the delay corresponds to the SIMD factor. | 08-25-2011 |
Jeffery A. Gladding, Burlington, MA US
Patent application number | Description | Published |
---|---|---|
20150065510 | Rilyazine Derivatives and Compositions for The Treatment of Cancer - The present application discloses Rilyazine analogs, methods for their preparation, and the treatment of cancer by the administration of an effective amount of the Rilyazine analogs to a patient in need thereof. | 03-05-2015 |
Jeffrey Allen Gladding, Burlington, MA US
Patent application number | Description | Published |
---|---|---|
20140094487 | Dihydro-6-Azaphenalene Derivatives for the Treatment of CNS, Oncological Diseases and Related Disorders - In one embodiment, the present application discloses 2-aza-, 2-oxa- and 2-thia-2,3-dihydro-6-azaphenalene compounds and compositions, and methods for treating a neurological disease in a patient in need thereof using the compounds and compositions as disclosed herein. | 04-03-2014 |
Patrick Gladding, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20110045481 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided. | 02-24-2011 |
Patrick A. Gladding, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20110060532 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided | 03-10-2011 |
Patrick A. Gladding, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20130096026 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided | 04-18-2013 |
20130096153 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided | 04-18-2013 |
20130096154 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided | 04-18-2013 |
20140206716 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided | 07-24-2014 |
Patrick Alton Gladding, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20160095826 | METHODS OF DIAGNOSIS AND TREATMENT - A method for diagnosing a cardiac ischemic event and a kit for detecting biomarkers used in the method. Also provided is a method for treating a PPAR-related disorder by administering a pharmaceutical composition containing one or more long chain fatty acids. | 04-07-2016 |